Previous Article |
Table of Contents
| Next Article
Commentary
Cytochrome P450 flexibility
Departments of Molecular Biology and Biochemistry, Physiology and Biophysics, and Chemistry, and Program in Macromolecular Structure, University of California, Irvine, CA 92697-3900
Cytochrome P450 refers to a group of enzymes that catalyze the monooxygenation of various organic molecules in the following reaction:
![]() |
P450s are best known for their role in drug metabolism and detoxification. Humans have 57 functional P450 genes and 46 pseudogenes (http://drnelson.utmem.edu/human.genecount.html), and several of these, located in liver microsomes, are induced by a variety of foreign organic molecules. Hydroxylation of these substances by P450s renders these relatively insoluble organic compounds more soluble for easier elimination. In addition, P450s participate in the metabolism of sex hormones, vitamin D, and bile acids in mammals (1, 2); ecdysones in insects (3); and terpenes in plants (4). P450s also play an important role in microorganisms in the use of various organic compounds as carbon sources and in the production of important natural products such as antibiotics.
P450s range in size from 40 to 50 kDa and contain a single heme group. Oxygen binds to the heme iron where the enzyme catalyzes cleavage of the oxygen OO bond, leaving behind an iron-linked oxygen atom that provides a potent oxidant. The substrate is held precisely in place such that the correct carbon atom is close to the iron-linked O atom for regio- and stereoselective hydroxylation. In general, those P450s involved in the production of important intermediates such as in steroid metabolism are highly specific. However, many of the drug-metabolizing P450s are not specific and are capable of hydroxylating a variety of diverse and unrelated compounds. Several P450 crystal structures now are known, and it was not too surprising, based on sequence alignments, that the overall fold is maintained in all P450s (Fig. 1). A particularly challenging problem, however, is
* E-mail: poulos@uci.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
Companion article to this Commentary:
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
Y. Hong, B. Yu, M. Sherman, Y.-C. Yuan, D. Zhou, and S. Chen Molecular Basis for the Aromatization Reaction and Exemestane-Mediated Irreversible Inhibition of Human Aromatase Mol. Endocrinol., February 1, 2007; 21(2): 401 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Achary, A. B. M. Reddy, S. Chakrabarti, S. G. Panicker, A. K. Mandal, N. Ahmed, D. Balasubramanian, S. E. Hasnain, and H. A. Nagarajaram Disease-Causing Mutations in Proteins: Structural Analysis of the CYP1b1 Mutations Causing Primary Congenital Glaucoma in Humans Biophys. J., December 15, 2006; 91(12): 4329 - 4339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Janner, A. V Pandey, P. E Mullis, and C. E Fluck Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein. Eur. J. Endocrinol., July 1, 2006; 155(1): 143 - 151. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Krone, Y. Grischuk, M. Muller, R. E. Volk, J. Grotzinger, P.-M. Holterhus, W. G. Sippell, and F. G. Riepe Analyzing the Functional and Structural Consequences of Two Point Mutations (P94L and A368D) in the CYP11B1 Gene Causing Congenital Adrenal Hyperplasia Resulting from 11-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2682 - 2688. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhao, F. P. Guengerich, A. Bellamine, D. C. Lamb, M. Izumikawa, L. Lei, L. M. Podust, M. Sundaramoorthy, J. A. Kalaitzis, L. M. Reddy, et al. Binding of Two Flaviolin Substrate Molecules, Oxidative Coupling, and Crystal Structure of Streptomyces coelicolor A3(2) Cytochrome P450 158A2 J. Biol. Chem., March 25, 2005; 280(12): 11599 - 11607. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Williams, J. Cosme, D. M. Vinkovic, A. Ward, H. C. Angove, P. J. Day, C. Vonrhein, I. J. Tickle, and H. Jhoti Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone Science, July 30, 2004; 305(5684): 683 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Dickmann, C. W. Locuson, J. P. Jones, and A. E. Rettie Differential Roles of Arg97, Asp293, and Arg108 in Enzyme Stability and Substrate Specificity of CYP2C9 Mol. Pharmacol., April 1, 2004; 65(4): 842 - 850. [Abstract] [Full Text] |
||||